Santa Fe, NM: State regulators have expended the pool of patients eligible to access medical cannabis products to include those with anxiety disorders. Members of the New Mexico Medical Cannabis Advisory Board approved the policy expansion, which takes effect on January 1, 2023.
A pair of physicians petitioned regulators to expand the scope of the program, opining that alternatives to conventional medications are needed to address the needs of those with treatment-resistant anxiety disorders.
Survey data indicates that those who consume cannabis for purposes of self-medication are most likely to do so to mitigate symptoms of pain, anxiety, and to improve sleep.
According to data compiled by the state’s Department of Health, over 130,000 New Mexicans are registered to access medical cannabis products.
Additional information on New Mexico’s medical cannabis law is available from NORML.